Benchmark Litigation

News and features

Articles

Article Type

Showing 1 - 10 of 12

News & Analysis

Optis v Apple: UK patent dispute judgments

05 July 2023 by Kingsley Egbuonu

IP STARS has compiled all the available English court judgments in the SEP and FRAND dispute between Optis and Apple
News & Analysis

IP people moves and firm announcements

31 May 2023 by Ye Zhang

Read the latest news about intellectual property practitioners and firms in Americas, Asia-Pacific and Europe
News & Analysis

IP people moves and firm announcements

27 April 2023 by Ye Zhang

Read the latest news about intellectual property practitioners and firms in Americas, Asia-Pacific and Europe
News & Analysis

Managing IP's Top 250 Women in IP 2023

26 April 2023 by Managing IP

We have confirmed this year's Top 250 Women in IP list
News & Analysis

IP people moves and firm announcements

31 January 2023 by Chris Adams and Kingsley Egbuonu

Read the latest news about intellectual property practitioners and firms in the Americas, Asia Pacific and Europe
News & Analysis

IP people moves and firm announcements

21 December 2022 by Liam McDaid

Read the latest news about intellectual property practitioners and firms in Europe
News & Analysis

Global law firms quit Russia: the latest updates

24 October 2022 by Managing IP Research Team

The war in Ukraine has prompted several international law firms to cease or reconsider their operations in Russia, a move that has created new independent law firms
News & Analysis

The latest news on mRNA patent cases

14 October 2022 by Kingsley Egbuonu

Read about some of the IP disputes concerning mRNA COVID-19 vaccines and the law firms involved
News & Analysis

Research results for the 2022 edition (final update)

04 October 2022 by Managing IP Research Team

We have published all the research results for the 2022 edition of IP STARS rankings and Managing IP Awards programme
News & Analysis

Moderna sues Pfizer over mRNA platform

30 August 2022 by Kingsley Egbuonu

Legal scholars have commented on Moderna's patent infringement action against Pfizer and BioNTech
Load more